deuruxolitinib

Sponsor TEVA Pharmaceutical Industries LTD · listed as TEVA

READOUT Phase 2;Phase 3 Confidence: medium Source: clinicaltrials

Next catalyst

Event typeREADOUT

Expected date2027-05-31

As disclosedMay 2027

Date precisionmonth

Confidencemedium

Verify at source →

Trial & sponsor

Trial (NCT)NCT03898479

PhasePHASE2;PHASE3

StatusACTIVE_NOT_RECRUITING

Lead sponsorSun Pharmaceutical Industries, Inc.

Listed asTEVA

Condition(s)Alopecia Areata

Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.

This is one row of the free CSA sample. The full snapshot carries 2,103 forward catalysts across 139 listed sponsors.

Get the full dataset — $499 → More TEVA catalysts